Clinical Trial Update: A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update assessing the safety, tolerability, and preliminary efficacy of BD111 in herpes simplex virus type I stromal keratitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Type Stromal Keratitis

Drugs mentioned

• BD111

Snippet

Sponsor: Shanghai BDgene Co., Ltd. | Conditions: Herpes Simplex Virus Type I Stromal Keratitis | Phase 1 | Status: ACTIVE_NOT_RECRUITING